GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amarin Corp PLC (FRA:EH3A) » Definitions » NonCurrent Deferred Liabilities

Amarin (FRA:EH3A) NonCurrent Deferred Liabilities : €1.9 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Amarin NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Amarin's non-current deferred liabilities for the quarter that ended in Mar. 2024 was €1.9 Mil.

Amarin NonCurrent Deferred Liabilities Historical Data

The historical data trend for Amarin's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amarin NonCurrent Deferred Liabilities Chart

Amarin Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.65 12.91 12.44 12.41 2.30

Amarin Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.86 3.08 2.76 2.30 1.94

Amarin NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Amarin's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Amarin (FRA:EH3A) Business Description

Industry
Traded in Other Exchanges
Address
112-114 St Stephens Green, Iconic Offices, The Greenway, Block C Ardilaun Court, Dublin, IRL, D02 TD28
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its lead product includes Vascepa.

Amarin (FRA:EH3A) Headlines

No Headlines